Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Gregory Forlenza

Concepts (221)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Insulin Infusion Systems
67
2023
306
15.010
Why?
Diabetes Mellitus, Type 1
89
2024
3357
12.000
Why?
Pancreas, Artificial
26
2022
71
9.510
Why?
Blood Glucose Self-Monitoring
63
2024
534
9.410
Why?
Blood Glucose
81
2024
1937
8.300
Why?
Insulin
69
2023
2153
6.880
Why?
Hypoglycemic Agents
65
2023
1031
6.610
Why?
Hypoglycemia
29
2023
401
6.230
Why?
Hyperglycemia
15
2023
313
3.700
Why?
Hematopoietic Stem Cell Transplantation
5
2022
535
2.380
Why?
Monitoring, Ambulatory
5
2018
84
1.870
Why?
Islets of Langerhans Transplantation
4
2017
68
1.680
Why?
Diabetes Mellitus
7
2022
939
1.610
Why?
Pancreatectomy
4
2017
165
1.530
Why?
Insulin-Secreting Cells
3
2023
327
1.520
Why?
Adolescent
53
2024
18339
1.470
Why?
Child
53
2024
19026
1.460
Why?
Humans
115
2024
118053
1.320
Why?
Biomedical Technology
2
2019
43
1.290
Why?
Verapamil
2
2023
32
1.150
Why?
Pancreatitis, Chronic
3
2017
39
1.150
Why?
Patient Education as Topic
3
2021
696
1.130
Why?
Young Adult
31
2023
10705
1.110
Why?
Telemedicine
3
2022
663
0.970
Why?
Technology
5
2023
81
0.920
Why?
Calcium Channel Blockers
1
2023
114
0.890
Why?
Algorithms
14
2020
1520
0.860
Why?
Adult
42
2024
31227
0.840
Why?
Male
47
2024
57370
0.810
Why?
Lymphoma
1
2023
179
0.810
Why?
Female
44
2024
61140
0.730
Why?
Patient Dropouts
1
2020
66
0.700
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2023
267
0.690
Why?
Child, Preschool
14
2023
9441
0.690
Why?
Personal Satisfaction
1
2020
183
0.670
Why?
Diabetes Mellitus, Type 2
5
2023
2159
0.650
Why?
Patient Satisfaction
2
2021
609
0.640
Why?
Artificial Intelligence
1
2019
136
0.630
Why?
Transplantation Conditioning
1
2019
152
0.620
Why?
Glucose
8
2023
939
0.600
Why?
Eczema
1
2018
85
0.600
Why?
Self-Management
1
2019
133
0.590
Why?
Diabetic Retinopathy
2
2024
160
0.590
Why?
Betacoronavirus
1
2020
253
0.580
Why?
Machine Learning
1
2020
320
0.580
Why?
Diffusion of Innovation
1
2017
97
0.570
Why?
Treatment Outcome
14
2023
9310
0.550
Why?
Insulin, Regular, Human
7
2023
32
0.530
Why?
Endocrine Glands
1
2015
16
0.530
Why?
Endocrine System Diseases
1
2015
32
0.510
Why?
Pneumonia, Viral
1
2020
347
0.500
Why?
Coronavirus Infections
1
2020
338
0.500
Why?
Fanconi Anemia
1
2013
12
0.480
Why?
Dwarfism
1
2013
17
0.480
Why?
Suicide
1
2020
496
0.470
Why?
Skin
1
2018
658
0.460
Why?
Growth Hormone
1
2013
107
0.460
Why?
Diabetic Ketoacidosis
4
2023
168
0.460
Why?
Quality of Life
2
2020
2360
0.440
Why?
Blindness
1
2012
35
0.430
Why?
Sequence Analysis, DNA
1
2015
745
0.420
Why?
High-Throughput Nucleotide Sequencing
1
2015
449
0.420
Why?
Pandemics
1
2020
1339
0.410
Why?
Aged
17
2022
19555
0.400
Why?
Randomized Controlled Trials as Topic
1
2016
1237
0.390
Why?
Angiogenesis Inhibitors
1
2012
218
0.380
Why?
Cross-Over Studies
5
2019
448
0.380
Why?
Cardiovascular Diseases
1
2022
1795
0.380
Why?
Calibration
3
2020
134
0.380
Why?
Lingual Frenum
1
2010
1
0.380
Why?
Retrospective Studies
9
2024
12921
0.370
Why?
Tongue Diseases
1
2010
8
0.370
Why?
Epidemics
1
2011
70
0.370
Why?
Failure to Thrive
1
2010
31
0.370
Why?
Vascular Endothelial Growth Factor A
1
2012
522
0.360
Why?
Infant
6
2023
8256
0.350
Why?
Double-Blind Method
4
2023
1679
0.350
Why?
Models, Biological
1
2016
1698
0.340
Why?
Middle Aged
18
2022
27431
0.330
Why?
Follow-Up Studies
5
2021
4571
0.320
Why?
Skiing
2
2019
38
0.310
Why?
Exercise
7
2019
1647
0.300
Why?
Adolescent Nutritional Physiological Phenomena
2
2017
25
0.300
Why?
Inventions
2
2018
17
0.300
Why?
Transplantation, Autologous
3
2017
190
0.290
Why?
United States
10
2023
12477
0.280
Why?
Postoperative Complications
2
2015
2230
0.280
Why?
Overweight
2
2023
492
0.280
Why?
Outpatients
2
2021
324
0.280
Why?
Endocrinology
2
2018
68
0.280
Why?
Risk Factors
5
2020
8949
0.270
Why?
Insulin Lispro
2
2022
35
0.270
Why?
Insulin Aspart
2
2022
26
0.270
Why?
C-Peptide
2
2023
139
0.270
Why?
Injections, Subcutaneous
3
2020
139
0.260
Why?
Feasibility Studies
5
2018
747
0.250
Why?
Body Height
2
2017
186
0.250
Why?
Mutation
1
2015
3426
0.250
Why?
Insulins
1
2023
34
0.220
Why?
Meals
3
2019
101
0.210
Why?
Equipment Failure
3
2018
114
0.210
Why?
Awareness
1
2023
92
0.210
Why?
Pediatrics
2
2020
980
0.200
Why?
Automobile Driving
1
2023
129
0.200
Why?
Medicaid
2
2022
410
0.190
Why?
Infusion Pumps, Implantable
1
2020
20
0.190
Why?
Smartphone
2
2019
68
0.180
Why?
Medicare
2
2022
666
0.180
Why?
Computer Systems
1
2020
47
0.180
Why?
Sports
2
2019
190
0.170
Why?
Prospective Studies
5
2023
6443
0.170
Why?
Product Surveillance, Postmarketing
1
2019
64
0.170
Why?
Fatal Outcome
1
2020
286
0.170
Why?
Prevalence
3
2023
2321
0.170
Why?
Reproducibility of Results
4
2024
2855
0.170
Why?
Software
2
2021
563
0.170
Why?
Biosensing Techniques
1
2020
106
0.160
Why?
Clinical Alarms
1
2017
10
0.160
Why?
Night Terrors
1
2017
1
0.150
Why?
Insulinoma
1
2017
29
0.150
Why?
Device Approval
1
2017
21
0.150
Why?
Diet, Diabetic
1
2017
34
0.150
Why?
Voluntary Health Agencies
1
2016
6
0.150
Why?
Survival Analysis
1
2020
1261
0.150
Why?
Adrenal Hyperplasia, Congenital
1
2017
29
0.150
Why?
Obesity
3
2023
2715
0.140
Why?
Program Evaluation
1
2021
834
0.140
Why?
United States Food and Drug Administration
1
2017
174
0.140
Why?
Pancreaticoduodenectomy
1
2017
128
0.140
Why?
Abdominal Pain
1
2017
133
0.140
Why?
Statistics as Topic
1
2016
304
0.130
Why?
Hypophosphatasia
1
2015
2
0.130
Why?
Drug Overdose
1
2020
293
0.130
Why?
Age Factors
3
2018
2989
0.130
Why?
Drug Delivery Systems
1
2018
306
0.130
Why?
Pilot Projects
2
2020
1405
0.130
Why?
Consensus
3
2023
531
0.130
Why?
Alkaline Phosphatase
1
2015
157
0.120
Why?
Autografts
1
2014
49
0.120
Why?
Clinical Decision-Making
1
2016
276
0.120
Why?
Choristoma
1
2013
22
0.120
Why?
Glucose Clamp Technique
1
2014
194
0.120
Why?
Primary Ovarian Insufficiency
1
2013
30
0.120
Why?
Infusions, Intravenous
1
2014
379
0.110
Why?
Postoperative Period
1
2014
307
0.110
Why?
Quality Improvement
1
2021
962
0.110
Why?
Graft Survival
1
2015
496
0.110
Why?
Allografts
1
2013
133
0.110
Why?
Patient Compliance
1
2017
532
0.110
Why?
Clinical Protocols
1
2014
234
0.110
Why?
Pituitary Gland
1
2013
163
0.110
Why?
Bionics
2
2022
11
0.110
Why?
Body Mass Index
2
2017
2074
0.110
Why?
Genetic Testing
1
2015
388
0.110
Why?
Pituitary Neoplasms
1
2013
165
0.110
Why?
Graft Rejection
1
2015
547
0.110
Why?
Adipose Tissue
1
2016
595
0.100
Why?
Adolescent Behavior
1
2017
480
0.100
Why?
Prognosis
2
2020
3420
0.100
Why?
Age of Onset
1
2012
463
0.100
Why?
Critical Illness
1
2016
662
0.090
Why?
Biomedical Research
1
2016
601
0.090
Why?
Activities of Daily Living
3
2017
353
0.090
Why?
Global Health
1
2012
308
0.090
Why?
Pancreatic Neoplasms
1
2017
719
0.090
Why?
Surveys and Questionnaires
1
2022
4682
0.090
Why?
Electronic Health Records
1
2016
809
0.090
Why?
Biomarkers
1
2020
3564
0.090
Why?
Guideline Adherence
1
2012
519
0.080
Why?
Case-Control Studies
1
2015
3142
0.080
Why?
Infant, Newborn
1
2019
5227
0.080
Why?
Cold Temperature
2
2019
130
0.080
Why?
Equipment Design
2
2019
517
0.080
Why?
Breast Feeding
1
2010
381
0.070
Why?
Weight Gain
1
2010
486
0.070
Why?
Incidence
1
2012
2413
0.070
Why?
Seasons
2
2019
462
0.070
Why?
Mass Screening
1
2012
1048
0.070
Why?
Child Abuse
1
2010
465
0.060
Why?
Practice Guidelines as Topic
1
2012
1434
0.060
Why?
Risk
2
2017
845
0.060
Why?
Longitudinal Studies
2
2024
2487
0.060
Why?
Combined Modality Therapy
2
2017
1162
0.060
Why?
Diet
1
2011
1143
0.060
Why?
Quality-Adjusted Life Years
1
2023
103
0.060
Why?
Insulin Resistance
1
2011
1167
0.060
Why?
Standard of Care
1
2023
63
0.050
Why?
Hospitalization
2
2024
1778
0.050
Why?
Reference Standards
1
2021
173
0.050
Why?
Intention to Treat Analysis
1
2020
70
0.050
Why?
Pancreas
1
2022
279
0.050
Why?
Cost-Benefit Analysis
1
2023
551
0.050
Why?
Inpatients
1
2024
388
0.050
Why?
Social Conditions
1
2019
13
0.040
Why?
Disease Management
1
2023
567
0.040
Why?
Equipment and Supplies
1
2018
38
0.040
Why?
International Cooperation
1
2018
174
0.040
Why?
Postprandial Period
1
2018
96
0.040
Why?
Time Factors
2
2018
6362
0.040
Why?
Virginia
1
2017
52
0.040
Why?
Mobile Applications
1
2020
145
0.040
Why?
Snacks
1
2017
17
0.040
Why?
Colorado
2
2017
4175
0.040
Why?
Accelerometry
1
2017
72
0.040
Why?
Reference Values
1
2018
764
0.040
Why?
Ohio
1
2017
140
0.040
Why?
Minnesota
1
2017
137
0.040
Why?
Child Nutritional Physiological Phenomena
1
2017
98
0.040
Why?
Single-Blind Method
1
2017
266
0.040
Why?
Hypertrophy
1
2016
121
0.030
Why?
Food Preferences
1
2017
118
0.030
Why?
Materials Testing
1
2017
360
0.030
Why?
Child Behavior
1
2017
213
0.030
Why?
Societies, Medical
1
2018
700
0.030
Why?
Pain Measurement
1
2017
468
0.030
Why?
Feeding Behavior
1
2018
594
0.030
Why?
Aged, 80 and over
1
2022
6533
0.020
Why?
Practice Patterns, Physicians'
1
2018
1195
0.020
Why?
Severity of Illness Index
1
2017
2652
0.020
Why?
Cohort Studies
1
2017
5072
0.020
Why?
Magnetic Resonance Imaging
1
2017
3160
0.020
Why?
Forlenza's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)